- Trials with a EudraCT protocol (95)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (1)
95 result(s) found for: Impedance.
Displaying page 1 of 5.
EudraCT Number: 2019-002187-26 | Sponsor Protocol Number: neostigmine2019 | Start Date*: 2019-08-28 |
Sponsor Name:KU Leuven - TARGID | ||
Full Title: A Prospective evaluation of the effect of a single dose of neostigmine in patients with patients with weak or absent esophageal peristalsis | ||
Medical condition: Patients with complaints of dysphagia and poor esophageal motility | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: BE (Completed) | ||
Trial results: View results |
EudraCT Number: 2009-017351-96 | Sponsor Protocol Number: baclofen2009 | Start Date*: 2009-12-23 |
Sponsor Name:UZleuven | ||
Full Title: A placebo controlled trial with Baclofen for the treatment of GERD patients with incomplete PPI response | ||
Medical condition: Gastroesophageal reflux disease | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: BE (Completed) | ||
Trial results: View results |
EudraCT Number: 2010-021390-36 | Sponsor Protocol Number: buspar2010 | Start Date*: 2010-09-07 |
Sponsor Name:uzleuven | ||
Full Title: The Effect of Acute Intake of Oral Buspirone Hydrochloride on Esophageal Motility, Bolus Transit and Symptoms of Dysphagia, in Patients with Ineffective Esophageal Motility: A Pilot, Open-label, Si... | ||
Medical condition: Ineffective Esophageal Motility | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: BE (Completed) | ||
Trial results: View results |
EudraCT Number: 2007-004208-11 | Sponsor Protocol Number: Kozek200701 | Start Date*: 2008-04-28 |
Sponsor Name:Medizinische Universität Wien, Univ.-Klinik für Spezielle Anästhesie und Schmerztherapie | ||
Full Title: Effect of chronic garlic intake on platelet function | ||
Medical condition: improvement in overall health status by garlic and preoperative setting | ||
Disease: | ||
Population Age: | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2017-004175-31 | Sponsor Protocol Number: Prucalopride2017 | Start Date*: 2018-04-09 |
Sponsor Name:TARGID, KU Leuven | ||
Full Title: A placebo-controlled trial with prucalopride for the treatment of typical reflux symptoms in patients with gastro-esophageal reflux disease with incomplete proton pump inhibitor response | ||
Medical condition: refractory gastro-esophageal reflux disease | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: BE (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2019-002182-35 | Sponsor Protocol Number: buspirone2019 | Start Date*: 2019-09-10 |
Sponsor Name:KU Leuven - TARGID | ||
Full Title: The effect of oral buspirone hydrochloride on esophageal motility, bolus transit and symptoms of dysphagia, in patients with poor esophageal motility: A randomized, double-blind, placebo controlle... | ||
Medical condition: Patients with complaints of dysphagia and poor esophageal motility | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: BE (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2010-023980-17 | Sponsor Protocol Number: Metformin 3.0 | Start Date*: 2011-08-24 |
Sponsor Name:St. Antonius Hospital | ||
Full Title: An efficacy, safety and pharmacokinetic study on the short-term and long-term use of METFORMIN in obese children and adolescents | ||
Medical condition: obese children and adolescents of Caucasian descent with insulin resistance in the age of ≥ 10 and ≤ 16 years at study entry. | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2012-002473-61 | Sponsor Protocol Number: GS-US-321-0102 | Start Date*: 2013-05-08 | |||||||||||
Sponsor Name:Gilead Sciences Inc | |||||||||||||
Full Title: A Phase 2b, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Safety and Efficacy of GS-6624, a Monoclonal Antibody Against Lysyl Oxidase Like 2 (LOXL2) in Subjects wi... | |||||||||||||
Medical condition: Primary Sclerosing Cholangitis (PSC) | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) GB (Completed) SE (Completed) IT (Completed) DK (Completed) ES (Completed) BE (Completed) NL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2019-004561-41 | Sponsor Protocol Number: FGC-19-003 | Start Date*: 2020-03-20 | |||||||||||
Sponsor Name:The Functional Gut Clinic | |||||||||||||
Full Title: The use of Antacids and Alginates during Pre-Investigation Proton Pump Inhibitor Washout: Impact on Compliance and Symptom Burden | |||||||||||||
Medical condition: Gastro-oesophageal reflux disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-001846-24 | Sponsor Protocol Number: 1 | Start Date*: 2016-06-29 |
Sponsor Name:Antwerp University Hospital | ||
Full Title: Metabolism of Isotonic versus Hypotonic Maintenance Solutions in fasting healthy Adults (MIHMoSA), a Single-Blind Randomized Crossover Trial | ||
Medical condition: Healthy adult volunteers | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: BE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2012-002488-88 | Sponsor Protocol Number: GS-US-321-0105 | Start Date*: 2013-07-29 | |||||||||||
Sponsor Name:Gilead Sciences Inc | |||||||||||||
Full Title: A Phase 2b, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Safety and Efficacy of GS-6624, a Monoclonal Antibody Against Lysyl Oxidase-Like 2 (LOXL2), in Subjects w... | |||||||||||||
Medical condition: Advanced Liver Fibrosis Secondary to Non-Alcoholic Steatohepatitis (NASH) | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) DE (Prematurely Ended) GB (Prematurely Ended) ES (Completed) BE (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-019072-68 | Sponsor Protocol Number: version 1 (07/10/2010) | Start Date*: 2010-12-31 |
Sponsor Name:Guy's & St Thomas' NHS Foundation Trust | ||
Full Title: A randomised, double blind, crossover study to determine the mechanism of action of Gaviscon Advance in Gastro-Oesophageal Reflux Disease (GORD) | ||
Medical condition: Gastro-oesophageal reflux disease (GORD) | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2017-004174-34 | Sponsor Protocol Number: Citalopram2017 | Start Date*: 2018-04-10 |
Sponsor Name:Targid, KU Leuven | ||
Full Title: A placebo-controlled trial with citalopram for the treatment of typical reflux symptoms in patients with reflux hypersensitivity or functional heartburn with incomplete proton pump inhibitor response | ||
Medical condition: Functional heartburn and reflux hypersensitivity with incomplete respons to proton pomp inhibitors | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: BE (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2012-000678-44 | Sponsor Protocol Number: GA1116 | Start Date*: 2012-09-04 |
Sponsor Name:Reckitt Benckiser Healthcare (UK) Ltd | ||
Full Title: A single-centre, randomised, four-way crossover study to investigate the measurement of the acid pocket and subsequent gastro-oesophageal reflux episodes using a novel pH/impedance catheter in subj... | ||
Medical condition: A single-centre, randomised, four-way crossover study to investigate the measurement of the acid pocket and subsequent gastro-oesophageal reflux episodes using a novel pH/impedance catheter in subj... | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: GB (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2011-002745-35 | Sponsor Protocol Number: rum_baclofen2011 | Start Date*: 2011-09-09 | ||||||||||||||||
Sponsor Name:UZLeuven | ||||||||||||||||||
Full Title: A placebo controlled trial with Baclofen for the treatment of patients with clinical suspicion of rumination syndrome or esophageal belching | ||||||||||||||||||
Medical condition: Rumination syndrome and supragastric belching | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: BE (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2006-003418-16 | Sponsor Protocol Number: Bac04018 | Start Date*: 2007-02-14 |
Sponsor Name:Academic Medical Center | ||
Full Title: The role of a hiatal hernia on the efficacy of anti-TLESR therapy in patients with gastroesophageal reflux disease | ||
Medical condition: Gastroesophageal reflux disease | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2012-002489-11 | Sponsor Protocol Number: GS-US-321-0106 | Start Date*: 2013-02-26 | |||||||||||
Sponsor Name:Gilead Sciences Inc | |||||||||||||
Full Title: A Phase 2b, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Safety and Efficacy of GS-6624, a Monoclonal Antibody Against Lysyl Oxidase-Like 2 (LOXL2), in Subjects w... | |||||||||||||
Medical condition: Compensated Cirrhosis Secondary to Non-Alcoholic Steatohepatitis (NASH) | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) GB (Prematurely Ended) ES (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-000870-51 | Sponsor Protocol Number: CMCS240281 | Start Date*: 2013-02-25 |
Sponsor Name:Unidad de Gestión Clínica de Endocrinología y Nutrición | ||
Full Title: RANDOMIZED CLINICAL TRIAL TO ASSESS THE EFFICACY OF TESTOSTERONE UNDECANOATE, METFORMIN, OR THE COMBINATION OF BOTH, FOR THE TREATMENT OF ISOLATED HYPOGONADOTROPIC HYPOGONADISM AND ERECTILE DYSFUNC... | ||
Medical condition: Isolated hypogonadotropic hypogonadism related to obesity | ||
Disease: | ||
Population Age: Adults | Gender: Male | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2018-000017-20 | Sponsor Protocol Number: ASS-Metamizol-DDI | Start Date*: 2018-07-17 |
Sponsor Name:Universitäts-Herzzentrum Freiburg • Bad Krozingen | ||
Full Title: Antiplatelet effect of acetylsalicylic acid in patients after cardiac surgery: Impact of dipyrone (metamizole) | ||
Medical condition: Antithrombotic therapy after surgical replacement of stenotic heart valve by a bioprosthesis or mitral valve repair | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2019-002185-13 | Sponsor Protocol Number: clebopride2019 | Start Date*: 2019-10-03 |
Sponsor Name:KU Leuven - TARGID | ||
Full Title: A Randomized, Double Blind, Placebo Controlled, Crossover Trial of Clebopride vs Placebo in the Treatment of Clinically Suspected Rumination. | ||
Medical condition: rumination syndrome | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: BE (Trial now transitioned) | ||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
